We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,380
Increased
6,046
Reduced
2,042
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJB icon
9501
ProShares Short High Yield
SJB
$51.8M
$242 ﹤0.01%
15
-6,143
-100% -$100K
AKTX
9502
Akari Therapeutics
AKTX
$13.8M
$237 ﹤0.01%
+5
New +$376
CTV.WS
9503
DELISTED
Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
$234 ﹤0.01%
+2,600
New +$210
XTWY icon
9504
BondBloxx Bloomberg Twenty Year Target Duration US Treasury ETF
XTWY
$251M
$232 ﹤0.01%
+6
New +$246
JDIV
9505
JPMorgan Dividend Leaders ETF
JDIV
$12.9M
$230 ﹤0.01%
+5
New +$239
GHG
9506
GreenTree Hospitality
GHG
$117M
$220 ﹤0.01%
+86
New +$241
UPV icon
9507
ProShares Ultra FTSE Europe
UPV
$17M
$218 ﹤0.01%
4
-4
-50% -$242
DRTS icon
9508
Alpha Tau Medical
DRTS
$1.06B
$217 ﹤0.01%
70
-1,109
-94% -$2.84K
UWMC.WS
9509
DELISTED
UWM Holdings Warrants
UWMC.WS
$217 ﹤0.01%
1,059
+951
+881% +$228
MIG icon
9510
VanEck Moody's Analytics IG Corporate Bond ETF
MIG
$19.4M
$211 ﹤0.01%
+10
New +$215
BTMWW
9511
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$209 ﹤0.01%
+3,165
New +$205
IPW icon
9512
iPower
IPW
$958K
$209 ﹤0.01%
1
LFT
9513
Lument Finance Trust
LFT
$34.6M
$209 ﹤0.01%
81
-4,071
-98% -$10.4K
SBFMW
9514
Sunshine Biopharma Inc Warrant
SBFMW
$94.9K
$208 ﹤0.01%
1,289
-600
-32% -$93
SSFI icon
9515
Day Hagan/Ned Davis Research Smart Sector Fixed Income ETF
SSFI
$29.1M
$208 ﹤0.01%
+10
New +$214
EMTY icon
9516
ProShares Decline of the Retail Store ETF
EMTY
$2.94M
$206 ﹤0.01%
+8
New +$211
PABD icon
9517
iShares Paris-Aligned Climate Optimized MSCI World ex USA ETF
PABD
$332M
$205 ﹤0.01%
+4
New +$216
ALFUW
9518
Centurion Acquisition Corp Warrant
ALFUW
$203 ﹤0.01%
+1,453
New +$158
TLTQ
9519
DELISTED
Tradr 1.75X Long TLT Quarterly ETF
TLTQ
$203 ﹤0.01%
+10
New +$224
EVGRW
9520
DELISTED
Evergreen Corporation Warrant
EVGRW
$203 ﹤0.01%
7,249
-590
-8% -$26
GSRTU
9521
DELISTED
GSR III Acquisition Corp Unit
GSRTU
$201 ﹤0.01%
+20
New +$200
RDAC
9522
Rising Dragon Acquisition Corp
RDAC
$39.3M
$200 ﹤0.01%
+20
New +$200
BIAFW icon
9523
bioAffinity Technologies
BIAFW
$151K
$199 ﹤0.01%
665
+198
+42% +$167
NEOVW icon
9524
NeoVolta Inc Warrant
NEOVW
$913K
$198 ﹤0.01%
99
-400
-80% -$691
ENZ
9525
DELISTED
Enzo Biochem, Inc.
ENZ
$198 ﹤0.01%
278

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,380 new positions and adding to 6,046 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,380 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.